Board of managment

BioGenCell is led by a team of seasoned executives who have many years of executive and technical experience in the biotechnology industry. The founding team has a proven track record in the creation and manufacturing of commercially available cellular products, which were proven safe and beneficial for treating severe heart diseases and peripheral arterial diseases.

Dr. Yael Porat, PHD

CEO, Founder

Dr. Porat is a specialist in the biotechnology industry, having worked as an innovator, scientist, advisor and director for both industry leaders and pioneering startups.

Prof. Michael Belkin, MD

Chief Scientific Officer, Co-Founder

Prof. Belkin has been involved in biotechnology ventures since the creation of the field and was involved in the establishment of over 15 medical start-ups in ophthalmology and other fields

Mr. Eyal Peleg, CPA, MBA

Chief Financial Officer, Co-Founder

Mr. Peleg has over 25 years experience in growing and managing professional teams as a CEO. He is currently a consultant to both start-ups and established companies on the issues of strategic planning,

Michael Barnea, Adv

Legal Advisor

Mr. Barnea is a senior partner at the law firm of Barnea & Co., where he specializes in technology-related sales, licensing and development transactions, and has advised technology…

Marc Dechamps

BioGenCell EU Administrator

Marc Dechamps is a biologist with extensive experience of more than 30 years in the Pharmaceutical industry, with expertise in market development for new products including infectious diseases, immunological disorders, cancer, CNS diseases and vaccines.

Expert Support

Prof. Frank J Veith

Dr. Veith graduated from Cornell University Medical School with Honors before completing an internship at Columbia-Presbyterian Hospital in New York and his surgical residency training at Peter Bent Brigham Hospital and Harvard Medical School.

Prof. Aaron Ciechanover

Nobel Prize laureate Prof. Aaron Ciechanover is a Distinguished Research Professor in the Faculty of Medicine at the Technion – Israel Institute of Technology in Haifa, Israel.

Prof. Martin Grajower

Dr. Martin Grajower, MD, is an endocrinology, diabetes & metabolism specialist in Bronx, NY and has been practicing for 40 years. He graduated from Albert Einstein College of Medicine  in 1973, is board-certified in both specialties and holds the title of Clinical Associate Professor of Medicine,

Dr. Michael Frogel

Dr. Frogel is an Associate Professor of Pediatrics at the Albert Einstein College of Medicine, Principal Investigator for the New York City Pediatric Disaster Coalition (PDC) and Medical Director of the Pediatric Disaster Mental Health Initiative at Maimonides Medical Center

Dr. Mark J Niven

Dr. Niven is the Director of Endocrine and Diabetes Unit, incorporating The Bildirici Center for Diabetes Care and Researchat at Sanz Medical Center–Laniado Hospital, Israel. In addition to making changes in lifestyle, the diabetes patient must enlist the assistance of a wide range of specialists for comprehensive treatment of the disease.

Dr. Shlomo Bulvik

Dr. Shlomo Bulvik, director of the Hematology Department at at Sanz Medical Center–Laniado Hospital, Israel. Dr. Bulvik is currently involved in two major studies in the field of leukemia. The research which received the approval of the Ethics (Helsinki) Committee, is at an advanced stage involving a great deal of patient participation.

Prof. Bruce Bachenheimer

Bruce Bachenheimer is a Clinical Professor of Management and Executive Director of the Entrepreneurship Lab at Pace University.